Abstract
We studied the effect of certain differentiation inducers—thymidine, sodium butyrate, and dimethyl sulfoxide—on the cells of parental line K562 and the derived sublines resistant to quinoline xenobiotics 2-(4-dimethylaminostyryl)quinoline 1-oxide or 4-nitroquinoline 1-oxide. The cells of the both derived sublines demonstrate cross-resistance to these xenobiotics, while the subline resistant to 2-(4"-dimethylaminostyryl)quinoline 1-oxide is also resistant to ethidium bromide and colchicine. Treatment of cells of the sublines with thymidine but neither sodium butyrate nor dimethyl sulfoxide for 2 or 4 days considerably increases intracellular content of hemoglobin as compared to the parental cells K562. The revealed effect is due to increased hemoglobin content in the cells rather than to the increased proportion of hemoglobin-containing cells, which results from decreased proliferation rate observed in all cases.
Similar content being viewed by others
REFERENCES
Adderley, S.R. and Fitzgerald, D.J., Oxidative Damage of Cardiomyocytes Is Limited by Extracellular Regulated Kinases 1/2-Mediated Induction of Cyclooxigenase-2, J.?Biol. Chem., 1999, vol. 274, pp. 5038–5046.
Andersson, L.C., Nilsson, K., and Gahmberg, C.G., K562-A Human Erythroleukemic Cell Line, Int. J. Cancer, 1979, vol. 23, pp. 143–147.
Andreev, V.P., Batocyrenova, E.G., Ryzhakov, A.V., and Rodina, L.L., Intramolecular Charge Transfer in the Series of Styryl Derivatives of Pyridine and Quinoline N-Oxides, Chem. Heterocycl. Comp., 1998, vol. 374, 1093–1102.
Anisimov, A.G., Bolotnikov, I.A., and Volkova, T.O., Effect of Thymidine and Phorbol 12-Myristate 13-Acetate on Erytroid Differentiation of K562 Cells and Their Sensitivity to Nonspecific Lysis by Rat Splenocytes, Byul. eksperim. biol. Med., 1999, vol. 128, no.11, pp. 521–524.
Anisimov, A.G., Bolotnikov, I.A., and Volkova, T.O., Changes in K562 Cells Sensitivity to Nonspecific Lysis by Human Leukocytes Induced by Sodium Butyrate, Dimethylsulfoxide, and Phorbol 12-Myristate 13-Acetate, Ontogenez, 2000a, vol. 31, no.1, pp. 47–52.
Anisimov, A.G., Volkova, T.O., Chekmasova, A.A., and Andreev, V.P., Relationship between Apoptogenic Activity in Certain Quinoline Derivatives and Their Capacity to Inhibit Erythroid Differentiation in K562 Cell Line), Tsitologiya, 2000b, vol. 42, no.3, p. 258.
Anisimov, A.G., Bolotnikov, I.A., Chekmasova, A.A., and Volkova, T.O., Relationship between in vitro Induced Cell Differentiation in Neoplastic Lines and Their Sensitivity to Nonspecific Lysis by Natural Killer Cells. Possible Mechanisms, Tsitologiya, 2000c, vol. 42, no.10, pp. 923–936.
Arcangeli, A., Ricupero, L., and Olivotto, M., Commitment to Differentiation of Murine Erythroleukemia Cells Involves Modulated Plasma Membrane Depolarization Through Ca2+-Activated K+ Channels, J. Cell Physiol., 1987, vol. 132, pp.?387–400.
Bailleul, B., Daubersies, P., Galiegue-Zouitina, S., and Loucheux-Lefebvre, M.H., Molecular Basis of 4-Nitroquinoline 1-Oxide Carcinogenesis, Jpn. J. Cancer Res., 1989, vol. 80, pp. 691–697.
Baliga, B.S., Mankad, M., Shah, A.K., and Mankad, V.N., Mechanism of Differentiation of Human Erythroleukemic Cell Line K562 by Hemin, Cell Prolif, 1993, vol. 26, pp.?519–529.
Bianchi, N., Ongaro, F., Chiarabelli, C., Gualandi, L., Mischiati, C., Bergamini, P., and Gambari, R., Induction of Erythroid Differentiation of Human K562 Cells by Cisplatin Analogs, Biochem. Pharmacol., 2000, vol. 60, pp. 31–40.
Chen, Y., Sokoloski, J.A., Chu, E., and Sartorelli, A.C., Regulation of the Expression of Enzymes Involved in the Replication of DNA in Chemically-Induced Granulocytic Differentiation of HL-60 Leukemia Cells, Leuk. Res., 1998, vol. 22, pp. 687–695.
Cory, J.G. and Mansell, M.M., Comparison of the Cytidine 5'-Diphosphate and Adenosine 5'-Diphosphate Reductase Activities of Mammalian Ribonucleotide Reductase, Cancer. Res., 1975, vol. 35, pp. 2327–2331.
Dumontet, C., Fabianowska-Majewska, K., Mantincic, D., Callet Bauchu, E., Tigaud, I., Gandhi, V., Lepoivre, M., Peters, G.J., Rolland, M.O., Wyczechowska, D., Fang, X., Gazzo, S., Voorn, D.A., Vanier-Viornery, A., and MacKey, J., Common Resistance Mechanisms to Deoxynucleoside Analogues in Variants of the Human Erythroleukaemic Line K562, Br. J. Haematol., 1999a, vol. 106, pp. 78–85.
Dumontet, C., Bauchu, E.C., Fabianowska, K., Lepoivre, M., Wyczechowska, D., Bodin, F., and Rolland, M.O., Common Resistance Mechanisms to Nucleoside Analogues in Variants of the Human Erythroleukemic Line K562, Adv. Exp. Med. Biol., 1999b, vol. 457, pp. 571–577.
Eisbruch, A., Blick, M., Evinger-Hodges, M.J., Beran, M., Andersson, B., Gutterman, J.U., and Kurzrock, R., Effect of Differentiation-Inducing Agents on Oncogene Expression in a Chronic Myelogenous Leukemia Cell Line, Cancer, 1988, vol. 62, pp. 1171–1178.
Elledge, S.J. and Davis, R.W., Identification and Isolation of the Gene Encoding the Small Subunit of Ribonucleotide Reductase from Saccharomyces Cerevisiae: DNA Damage-Inducible Gene Required for Mitotic Viability, Mol. Cell. Biol., 1987, vol. 7, pp. 2783–2793.
Elledge, S.J. and Davis, R.W., DNA Damage Induction of Ribonucleotide Reductase, Mol. Cell. Biol., 1989a, vol. 9, pp. 4932–4940.
Elledge, S.J. and Davis, R.W., Identification of the DNA Damage-Responsive Element of RNR2 And Evidence That Four Distinct Cellular Factors Bind It, Mol. Cell. Biol., 1989b, vol. 9, pp. 5373–5386.
Elledge, S.J. and Davis, R.W., Two Genes Differentially Regulated in the Cell Cycle and by DNA-Damaging Agents Encode Alternative Regulatory Subunits of Ribonucleotide Reductase, Genes Dev., 1990, vol. 4, pp. 740–751.
Gahmberg, C.G. and Andersson, L.C., K562-A Human Leukemia Cell Line with Erythroid Features, Semin. Hematol., 1981, vol. 18, pp. 72–77.
Garcia-Bermejo, L., Vilaboa, N.E., Perez, C., De Blas, E., and Aller, P., Modulation of Heat-Shock Protein 70 (HSP70) Gene Expression by Sodium Butyrate in U-937 Promonocytic Cells: Relationships with Differentiation and Apoptosis, Exp. Cell Res., 1997, vol. 236, pp. 268–274.
Grinchuk, T.M., Pavlenko, M.A., Lipskaya, L.A., Sorokina, E.A., Tarunina, M.V., Berezkina, E.V., Kovaleva, Z.V., and Ignatova, T.N., Resistance of Human Erythroleukemia K562 Cells to Adriamycin Correlates with Targeted Genome Destabilizing-MDR1 Gene Amplification and Induced Changes in the Karyotype Structure, Tsitologiya, 1998, vol. 40, no.7, pp. 652–660.
Iyamu, E.W., Adunyah, S.E., Elford, H.L., Fasold, H., and Turner, E.A., Trimidox-Mediated Morphological Changes during Erythroid Differentiation Is Associated with the Stimulation of Hemoglobin and F-Cell Production in Human K562 Cells, Biochem. Biophys. Res. Commun., 1998, vol. 247, pp. 759–764.
Iyamu, W.E., Adunyah, S.E., Fasold, H., Horiuchi, K., Elford, H.L., Asakura, T., and Turner, E.A., Enhancement of Hemoglobin and F-Cell Production by Targeting Growth Inhibition and Differentiation of K562 Cells with Ribonucleotide Reductase Inhibitors (Didox and Trimidox) in Combination with Streptozotocin, Am. J. Hematol., 2000, vol. 63, pp. 176–183.
Jelinek, J., Rafferty, J.A., Cmejla, R., Hildinger, M., Chinnasamy, D., Lashford, L.S., Ostertag, W., Margison, G.P., Dexter, T.M., Fairbairn, L.J., and Baum, C., A Novel Dual Function Retrovirus Expressing Multidrug Resistance 1 and O6-Alkylguanine-DNA-Alkyltransferase for Engineering Resistance of Haemopoietic Progenitor Cells to Multiple Chemotherapeutic Agents, Gene Ther., 1999, vol. 6, pp. 1489–1493.
Johnson, S.A., Clinical Pharmacokinetics of Nucleoside Analogues: Focus on Haematological Malignancies, Clin. Pharmacokinet., 2000, vol. 39, pp. 5–26.
Knaust, E., Porwit-MacDonald, A., Gruber, A., Xu, D., and Peterson, C., Heterogeneity of Isolated Mononuclear Cells from Patients with Acute Myeloid Leukemia Affects Cellular Accumulation and Efflux of Daunorubicin, Haematologica, 2000, vol. 85, pp. 124–132.
Krishna, R. and Mayer, L.D., Multidrug Resistance (MDR) in Cancer. Mechanisms, Reversal Using Modulators of MDR and the Role of MDR Modulators in Influencing the Pharmacokinetics of Anticancer Drugs, Eur. J. Pharm. Sci., 2000, vol. 11, pp. 265–283.
Lea, M.A. and Randolph, V.M., Induction of Reporter Gene Expression by Inhibitors of Histone Deacetylase, Anticancer Res., 1998, vol. 18, pp. 2717–2722.
Levy, J., Terada, M., Rifkind, R.A., and Marks, P.A., Induction of Erythroid Differentiation by Dimethylsulfoxide in Cells Infected with Friend Virus: Relationship to the Cell Cycle, Proc. Natl. Acad. Sci. USA, 1975, vol. 72, pp. 28–32.
Maccarrone, M., Nieuwenhuizen, W.E., Dullens, H.F., Catani, M.V., Melino, G., Veldink, G.A., Vliegenthart, J.F., and Finazzo Agro, A., Membrane Modifications in Human Erythroleukemia K562 Cells during Induction of Programmed Cell Death by Transforming Growth Factor Beta 1 or Cisplatin, Eur. J. Biochem., 1996, vol. 241, pp. 297–302.
Morley, P. and Whitfield, J.F., The Differentiation Inducer, Dimethyl Sulfoxide, Transiently Increases the Intracellular Calcium Ion Concentration in Various Cell Types, J. Cell Physiol., 1993, vol. 156, pp. 219–225.
Morrow, C.S., Diah, S., Smitherman, P.K., Schneider, E., and Townsend, A.J., Multidrug Resistance Protein and Glutathione S-Transferase P1-1 Act in Synergy to Confer Protection from 4-Nitroquinoline 1-Oxide Toxicity, Carcinogenesis, 1998, vol. 19, pp. 109–115.
Ochiai, E., Aromatic Amino N-Oxides, Amsterdam: Elsevier, 1967.
Okano, T., Uekama, K., and Taguchi, E., Electronic Properties of N-Heteroaromatics. XXXV. Further Observations on the Charge Transfer Interaction of the Carcinogen, 4-Nitroquinoline 1-Oxide, with DNA and Deoxyribonucleosides: Analysis of the Visible Difference Bands, Jpn. J. Cancer Res., 1969, vol. 60, pp. 295–305.
Panigrahi, G.B. and Walker, I.G., The Reaction of Acetyl-4-Hydroxyaminoquinoline 1-Oxide with DNA: Quantitation of Single-Strand Break Formation and Hyper-Reactivity of DNA Termini, Carcinogenesis, 1991, vol. 12, pp. 963–967.
Parodi, M.T., Varesio, L., and Tonini, G.P., Morphological Change and Cellular Differentiation Induced by Cisplatin in Human Neuroblastoma Cell Lines, Cancer Chemother. Pharmacol., 1989, vol. 25, pp. 114–116.
Prados, J., Melguizo, C., Marchal, J.A., Velez, C., Alvarez, ?L., and Aranega, A., Therapeutic Differentiation in a Human Rhabdomiosarcoma Cell Line Selected for Resistance to Actinomycin D, Int. J. Cancer, 1998, vol. 75, pp. 379–383.
Racke, F.K., Lewandowska, K., Goueli, S., and Goldfarb, A.N., Sustained Activation of the Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Is Required for Megakaryocytic Differentiation of K562 Cells, J. Biol. Chem., 1997, vol. 272, pp. 23366–23370.
Reynolds, E.C., Harris, A.W., and Finch, L.R., Deoxyribonucleoside Triphosphate Pools and Differential Thymidine Sensitivities of Cultured Mouse Lymphoma and Myeloma Cells, Biochim. Biophys. Acta, 1979, vol. 561, pp. 110–123.
Rimet, O., Mirrione, A., and Barra, Y., Multidrug-Resistant Phenotype Influences the Differentiation of a Human Colon Carcinoma Cell Line, Biochem. Biophys. Res. Commun., 1999, vol. 259, pp. 43–49.
Serafino, A., Sinibaldi-Vallebona, P., Pierimarchi, P., Bernard, P., Gaudiano, G., Massa, C., Rasi, G., and Ranagnan, G., Induction of Apoptosis in Neoplastic Cells by Anthracycline Antitumor Drugs: Nuclear and Cytoplasmic Triggering?, Anticancer Res., 1999, vol. 19, pp. 1909–1918.
Solary, E., Bertrand, R., and Pommier, Y., Apoptosis of Human Leukemic HL-60 Cells Induced to Differentiate by Phorbol Ester Treatment, Leukemia, 1994, vol. 8, pp. 792–797.
Stromskaya, T.P., Filippova, N.A., Rybalkina, E.Yu., Egudina, S.V., Shtil, A.A., Eliseenkova, A.V., and Stavrovskaya, A.A., Alterations of Melanin Synthesis in Human Melanoma Cells Selected in vitro for Multidrug Resistance, Exp. Toxicol. Pathol., 1995, vol. 47, pp. 157–166.
Stromskaya, T.P., Rybalkina, E.Y., Shtil, A.A., Zabotina, T.N., Filippova, N.A., and Stavrovskaya, A.A., Influence of Exogenous RAR Alpha Gene on MDR1 Expression and P-Glycoprotein Function in Human and Rodent Cell Lines, Br. J. Cancer, 1998, vol. 77, pp. 1718–1725.
Sugimura, T., Okabe, K., and Nagao, M., The Metabolism of 4-Nitroquinoline-1-Oxide, a Carcinogen. 3. An Enzyme Catalyzing the Conversion of 4-Nitroquinoline-1-Oxide to 4-Hydroxyaminoquinoline-1-Oxide in Rat Liver and Hepatomas, Cancer Res., 1966, vol. 26, pp. 1717–1721.
Szekeres, T., Vielnascher, E., Novotny, L., Vachalkova, A., Fritzer, M., Findenig, G., Gobl, R., Elford, H.L., and Goldenberg, H., Iron Binding Capacity of Trimidox (3,4,5-Trihydroxybenzamidoxime), a New Inhibitor of the Enzyme Ribonucleotide Reductase, Eur. J. Clin. Chem. Clin. Biochem., 1995, vol. 33, pp. 785–789.
Tada, M. and Tada, M., Seryl-tRNA Synthetase and Activation of the Carcinogen 4-Nitroquinoline 1-Oxide, Nature, 1975, vol. 255, pp. 510–512.
Takeshita, H., Kusuzaki, K., Murata, H., Suginoshita, T., Hirata, M., Hashiguchi, S., Ashihara, T., Gebhardt, M.C., Mankin, H.J., and Hirasawa, Y., Osteoblastic Differentiation and P-Glycoprotein Multidrug Resistance in a Murine Osteosarcoma Model, Br. J. Cancer, 2000, vol. 82, pp. 1327–1331.
Urbano, A., Koc, Y., and Foss, F.M., Arginine Butyrate Downregulates P210 Bcr-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells, Leukemia, 1998, vol. 12, pp. 930–936.
Wang, S. and Cai, G., Clinical Study of Multi-Drug Resistance Gene (MDR1) Expression in Primary Ovarian Cells, J.?Tongji. Med. Univ., 1998, vol. 18, pp. 58–60.
Witt, O., Sand, K., and Pekrun, A., Butyrate-Induced Erythroid Differentiation of Human K562 Leukemia Cells Involves Inhibition of ERK and Activation of P38 MAP Kinase Pathways, Blood, 2000, vol. 95, pp. 2391–2396.
Yamada, H., Horiguchi-Yamada, J., Nagai, M., Takahara, S., Sekikawa, T., Kawano, T., Itoh, K., Fukumi, S., and Iwase, S., Biological Effects of a Relatively Low Concentration of 1-Beta-D-Arabinofuranosylcytosine in K562 Cells: Alterations of the Cell Cycle, Erythroid-Differentiation, and Apoptosis, Mol. Cell. Biochem., 1998, vol. 187, pp. 211–220.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anisimov, A.G., Chekmasova, A.A., Volkova, T.O. et al. Erythroid Differentiation of K562 Cells Resistant to 2-(4"-Dimethylaminostyryl)quinoline-1-Oxide or 4-Nitroquinoline 1-Oxide Is Considerably Induced after Thymidine Treatment. Biology Bulletin 30, 220–227 (2003). https://doi.org/10.1023/A:1023895426255
Issue Date:
DOI: https://doi.org/10.1023/A:1023895426255